Inflammatory markers associated with albuminuria and early atherosclerosis in type 2 diabetic kidney disease: a cross-sectional study.

Background: Albuminuria is a recognized marker of renal injury in diabetic kidney disease (DKD), and growing evidence suggests it may also drive systemic inflammation and atherosclerosis. However, mechanisms linking albuminuria to vascular disease remain unclear. Methods: We conducted a cross-sectional study including 362 subjects with type 2 diabetes and moderate chronic kidney disease (CKD) to evaluate the associations between albuminuria, circulating and leukocyte inflammatory markers, and measures of subclinical atherosclerosis (SA). SA was defined by carotid intima-media thickness (CIMT) ≥0.9 mm or ankle-brachial index (ABI) <0.9. Serum levels of hs-CRP, IL6, IL1β, IL10, and TNFα and gene expression in peripheral blood leukocyte cells for Results: SA was present in 46% of patients. UACR correlated directly with CIMT (r=0.32, p<0.001) and inversely with ABI (r=-0.29, p<0.01). Higher UACR was associated with increased circulating IL6 and IL1β, and elevated expression of Conclusions: Albuminuria was positively associated with heightened systemic and cellular inflammation, and several inflammatory markers were also associated with greater CIMT and the presence of early atherosclerosis. Exploratory mediation analyses suggested that inflammatory pathways may partly account for the association between albuminuria and SA, with IL6, IL1β, and TLR2 as key mediators; however, these findings should be interpreted cautiously due to the cross-sectional design.